Loncastuximab Tesirine 43624-0004-01
- Manufacturer
- Bsp Pharmaceuticals S.p.a.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- May 1, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Loncastuximab Tesirine | 10 mg/2.2mL |
Selected Package
43624-0004-01Selected5 TRAY in 1 BOX (43624-004-01) / 120 VIAL in 1 TRAY / 2.2 mL in 1 VIAL